Nancy Phelan

Nancy R. Phelan has served as a member of our Board of Directors since January 2025. Nancy currently serves as Senior Vice President of Marketing & Analytics at Phathom Pharmaceuticals, a biopharmaceutical company focused on gastrointestinal diseases. She has served as a member of the board of directors of Medexus Pharmaceuticals, a specialty pharmaceutical company focusing on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology, since September 2023, and was previously an independent board member of FemmePharma Consumer Healthcare, a pharmaceutical company dedicated to developing treatment options to address diseases and disorders that disproportionately affect women. From May 2024 to October 2025, she served as Senior Vice President & Head of Customer Engagement at Trinity Life Sciences, a leader in strategy, insights and analytics for the life sciences industry. Prior to that, Nancy served as Senior Vice President of Indegene, a technology-led healthcare solutions provider. She also previously held roles of increasing responsibility with Novartis, a global leader in developing and delivering innovative medicines for serious diseases, including as Vice President, Business Transformation, Patient Engagement and Integrated Marketing Team Lead from April 2021 to May 2022 and Vice President, Patient and Specialty Services, Neuroscience from June 2002 to April 2021. She served as Chief Executive Officer and Secretary of Adhera Therapeutics, Inc., a company focused on the discovery, development, and commercialization of small molecule drugs, from April 2019 to June 2020 and as a director from October 2018 to June 2020. Nancy received a BA with Honors from Franklin & Marshall College and completed coursework towards an MBA from Villanova University. She also received certificates from Wharton Executive Education and the Harvard School of Public Health.